Vascular Access Devices Market Report: Market Size & Forecast 2026

Vascular access devices are medical instruments designed to provide safe and reliable access to the vascular system for the delivery of therapies, collection of blood samples, and monitoring of patients. The global market for these devices was valued at approximately $7.46 billion in 2025 and is expected to grow at a steady pace, reflecting the essential nature of these products across hospitals, clinics, and home care settings. As vascular disease remains a major health concern affecting arteries, veins, and lymph vessels, demand for reliable access solutions continues to rise globally.

• •Market valued at $7.46 billion in 2025 with 5.99% annual growth trajectory
• •Includes peripherally inserted central catheters (PICCs), central venous catheters (CVCs), ports, and peripheral IV catheters
• •Driven by widespread need for long-term intravenous therapy and hemodialysis access

The increasing burden of chronic conditions such as kidney disease, cancer, and diabetes has significantly expanded the patient population requiring vascular access for ongoing treatment. An aging global population with higher incidence of vascular disorders and reduced vascular integrity further amplifies demand for these devices. Additionally, the shift toward outpatient and home-based care models is driving adoption of vascular access solutions that enable safe, long-term use outside traditional hospital environments.

• •Rising prevalence of chronic kidney disease and end-stage renal disease driving dialysis catheter demand
• •Growing cancer treatment rates increasing need for central venous access ports and PICC lines
• •Advancements in antimicrobial and antithrombotic coatings reducing complication rates and extending device usability

The market is segmented by product type into central vascular access devices, peripheral devices, and implanted ports, with central catheters representing the largest segment due to their critical role in intensive care and chemotherapy administration. Geographically, North America commands the largest market share, supported by advanced healthcare infrastructure, high healthcare spending, and favorable reimbursement policies. The Asia-Pacific region is emerging as the fastest-growing market, fueled by expanding medical facilities, rising disease burden, and growing awareness of vascular access best practices.

• •Central vascular access devices dominate the product segment, followed by peripheral IV catheters and implantable ports
• •North America leads regional markets, with United States accounting for the majority of share
• •Asia-Pacific projected to experience highest growth rate due to healthcare modernization in China, India, and Southeast Asia

What are the recent trends and outlook?

The market is witnessing a strong shift toward antimicrobial and antithrombotic surface technologies designed to reduce catheter-associated bloodstream infections and thrombosis, which remain significant clinical concerns. Integrated closed catheter systems and needle-free connectors are gaining adoption as healthcare facilities implement enhanced safety protocols. Looking ahead, continued product innovation, expansion in emerging markets, and growing emphasis on patient safety and comfort are expected to sustain the market's growth trajectory over the forecast period.

• •Antimicrobial and heparin-coated catheters gaining adoption to combat hospital-acquired infections and extend dwell times
• •Needle-free connector technology and closed-loop systems becoming standard in infection prevention protocols
• •Growing emphasis on ultrasound-guided insertion techniques improving first-stick success rates and reducing complications